Delivery Order SPE2DB24D1201-SPE2DB24FJAJW

Award Date 7/1/24
Potential Completion Date 7/2/24
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,100.38 firm fixed-price delivery order is for the supply of Repatha 140 mg/mL SureClick medication. The contract has a completion date of May 3, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product Repatha 140 mg/mL SureClick. The $12,113.72 contract has a period of performance through March 18, 2024 and does not utilize any set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,300.77 firm fixed-price delivery order is for the supply of Repatha 140 mg/ml SureClick medication. The contract has an ultimate completion date of May 7, 2025 and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a major pharmaceutical distributor, a $1,525.23 firm fixed-price delivery order contract (SPE2DB22D1103|SPE2DB24FTQF3) for the supply of Repatha 140 mg/mL SureClickML. This award is not associated with a set-aside program. Amerisourcebergen, through its Corporate Office division, will deliver the pharmaceutical product to support the DLA's medical programs and supply military treatment facilities. The contract has an...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,028.00 firm fixed-price delivery order is for the supply of Repatha 140 mg/ml SureClickML, a specialty medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which covers a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded a $25,227.20 firm fixed price delivery order contract to AmerisourceBergen Drug Corp for the supply of 4565699511 - Repatha 140 mg/ml SureClick - a specialty medication. This delivery order falls under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide....
This federal contract award is for the delivery of Repatha 140 mg/ml SureClick medication to the Defense Logistics Agency (DLA). The $7,167.57 firm-fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 8, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
The U.S. Department of Defense's Medical Supply Chain (also known as the Defense Logistics Agency (DLA) Troop Support Medical) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $1,884.95, is for the delivery of Repatha 420 mg/3.5 ml Pushtronx 3.5 ml, a specialty pharmaceutical product. This delivery order falls under a larger indefinite delivery contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,198.85 firm fixed-price delivery order is for the supply of Repatha 140 mg/mL SureClick medication. The contract has an ultimate completion date of May 12, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,573.63 delivery order is for the supply of Repatha 140 mg/mL SureClick, a specialty medication used to treat cardiovascular conditions. The contract has a firm fixed price pricing type and runs through September 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
  • SPE2DB24D1201
    Indefinite Delivery Contract
  • SPE2DB24D1201-SPE2DB24FJAJW
    Delivery Order

The U.S. Defense Logistics Agency (DLA) has awarded a delivery order contract to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the federal government. The $2,910.60 firm-fixed-price contract is for the provision of Repatha 140 mg/ml SureClickML, a specialty medication. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this single-award IDC, Amerisourcebergen serves as the primary supplier of a comprehensive range of pharmaceuticals and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.

Generated 9/30/24, 1:09 PM